三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

秋霞理论理论福利院久久| 国产亚洲一区二区三不卡| 无码精品一区二区三区免费视频| 99久久婷婷精品国产综合| 亚洲免费一级黄片911| 精品美女少妇一区二区三区| 人妻888久久中文字幕| 久久九九视频观看一区免费| 日本av亚洲欧美av二区| 三极片在线视频| 乡村少妇一区二区三区蜜桃| 色多多国产中文字幕在线| 纤夫的爱在线观看完整版动漫| 国产精品国产三级在线观看| 亚洲精品一级片在线观看| 日韩精品一区二区在线视频| 97久久精品国产精品青草| 国产欧美日韩精品a在线观看 | 亚洲精品日韩黄片免费看| 欧美激情精品久久久久精品| 欧美成A高清在线观看。| 激情动态图亚洲区域激情| 国产精品久久久久久电影| 国产强伦姧在线观看剧情| 亚洲2022国产成人精品无码区| 伊人久久精品无码二区麻豆| 黑人巨大精品欧美一区二区免费| 动漫3d成人h无码国漫| 精品亚洲区二区中文字幕| av日韩精品一区在线观看| 国产精品国产三级国产在线| 自拍偷拍一区二区porn| 在线观看玩肥胖女人的屄| 肉动漫久久一区二区三区| 色六月婷婷亚洲婷婷六月| 亚洲国产一区二区精品专区发布 | 精品国产迷系列在线观看 | 亚洲欧美日韩区在线观看| 精品人妻蜜臀一区二区三区 | 最近中文国语字幕在线播放| 99久久久一区二区三区|